References
- SoulesMRShermanSParrottEExecutive summary: stages of reproductive aging workshop (STRAW)J Womens Health Gend Based Med200110984384811747678
- The North American Menopause SocietyEstrogen and progestogen use in postmenopausal women: 2010 position statement of the North American Menopause SocietyMenopause201017224225520154637
- BlumelJEChedrauiPBaronGA large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-age womenMenopause201118777878521407137
- PolitiMCSchleinitzMDColNFRevisiting the duration of vasomotor symptoms of menopause: a meta-analysisJ Gen Intern Med20082391507151318521690
- ThurstonRCJoffeHVasomotor symptoms and menopause: findings from the Study of Women’s Health across the NationObstet Gynecol201138489501
- GoldEBColvinAAvisNLongitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women’s health across the nationAm J Public Health20069671226123516735636
- FordKSowersMCrutchfieldMWilsonAJannauschMA longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopauseMenopause200512330831715879920
- MelbyMKAndersonDSievertLLObermeyerCMMethods used in cross-cultural comparisons of vasomotor symptoms and their determinantsMaturitas201170211011921871743
- BryantCJuddFKHickeyMAnxiety during the menopausal transition: a systematic reviewJ Affect Disord7212011 [Epub before print.]
- DeecherDCDorriesKUnderstanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stagesArch Womens Ment Health20071024725718074100
- RossmanithWGRuebberdtWWhat causes hot flashes? The neuroendocrine origin of vasomotor symptoms in the menopauseGynecol Endocrinol200925530331419903037
- WalkerEMRodriquezAIKohnBAcupuncture versus venlafaxine for management of vasomotor symptoms in patients with hormone receptor positive breast cancer: a randomized, clinical trialJ Clin Oncol201028463464020038728
- AvisNELegaultCCoeytauxRRA randomized, controlled pilot study of acupuncture treatment for menopausal hot flashesMenopause20081561070107818528313
- ChoSHWhangWWAcupuncture for vasomotor menopausal symptoms: a systematic reviewMenopause20091651065107319424092
- ElkinsGMarcusJStearnsVHasan RajabMPilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivorsPsychooncology200716548749217048223
- ElkinsGMarcusJStearnsVRandomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivorsJ Clin Oncol200826315022502618809612
- The North American Menopause SocietyTreatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause SocietyMenopause2004111113314716179
- DaleyAMacArthurCMutrieNExercise for vasomotor menopausal symptomsCochrane Database Syst Rev20074CD00610817943886
- ThackerHLAssessing risks and benefits of nonhormonal treatments for vasomotor symptoms in perimenopausal and postmenopausal womenJ Womens Health201120710071016
- KronenbergFFugh-BermanAComplementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trialsAnn Intern Med20021371080581312435217
- ShamsTSetiaMSHemmingsRMcCuskerJSewitchMCiampiAEfficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysisAltern Ther Health Med2010161364420085176
- BaiWHenneicke-von ZepelinHHWangSEfficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tiboloneMaturitas2007581314117587516
- PockajBAGallagherJGLoprinziCLPhase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1J Clin Oncol200624182836284116782922
- GellerSEShulmanLPvan BreemenRBSafety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trialMenopause20091661156116619609225
- NaserBSchnitkerJMinkinMJde ArribaSGNolteKUOsmersRSuspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extractMenopause201118436637521228727
- UebelhackRBlohmerJUGraubaumHJBuschRGruenwaldJWerneckeKDBlack cohosh and St John’s wort for climacteric complaints: a randomized trialObstet Gynecol200610724725516449108
- StomatiMMonteleonePCasarosaESix-month oral dehydroepiandrosterone supplementation in early and late postmenopauseGynecol Endocrinol200014534236311109974
- ChenoyRHussainSTayobYO’BrienPMMossMYMorsePFEffect of oral gamolenic acid from evening primrose oil on menopausal flushingBMJ199430869275015038136666
- St GermainAPetersonCTRobinsonJGAlekelDLIsoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatmentMenopause200181172611201510
- NelsonHDVescoKKHaneyENonhormonal therapies for menopausal hot flashes: systematic review and meta-analysisJAMA2006295172057207116670414
- KrebsEEEnsrudKEMacDonaldRWiltTJPhytoestrogens for treatment of menopausal symptoms: a systematic reviewObstet Gynecol2004104482483615458907
- TakuKMelbyMKKronenbergFKurzerMSMessinaMExtracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trialsMenopause3192012 [Epub before print.]
- TiceJAEttingerBEnsrudKWallaceRBlackwellTCummingsSRPhytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trialJAMA2003290220721412851275
- LewisJENickellLAThompsonLUSzalaiJPKissAHilditchJRA randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopauseMenopause200613463164216837885
- BartonDLLoprinziCLQuellaSKProspective evaluation of vitamin E for hot flashes in breast cancer survivorsJ Clin Oncol19981624955009469333
- MacLennanAHBroadbentJLLesterSMooreVOral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushesCochrane Database Syst Rev20044CD00297815495039
- RossouwJEAndersonGLPrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trialJAMA2002288332133312117397
- Livial (tibolone) [package insert]Cambridge, MAOrganon Laboratories2006
- ModelskaKCummingsSTibolone for postmenopausal women: systematic review of randomized trialsJ Clin Endocrinol Metab2002871162311788614
- BeralVBreast cancer and hormone-replacement therapy in the Million Women StudyLancet2003362938241942712927427
- KenemansPBundredNJFoidartJMSafety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trialLancet Oncol200910213514619167925
- ArcherDFTissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptomsDrugs Aging201027753354420583848
- PickarJHYehITBachmanGEndometrial effects of a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens as a menopausal therapyFertil Steril200992101018102419635613
- GoldbergRMLoprinziCLO’FallonJRTransdermal clonidine for ameliorating tamoxifen-induced hot flashesJ Clin Oncol19941211551588270972
- PandyaKJRaubertasRFFlynnPJOral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program studyAnn Intern Med20001321078879310819701
- GuttusoTKurlanRMcDermottMPKieburtzKGabapentin’s effects on hot flashes in postmenopausal women: a randomized controlled trialObstet Gynecol2003101233734512576259
- PandyaKJMorrowGRRoscoeJAGabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trialLancet2005366948881882416139656
- ReddySYWarnerHGuttusoTGabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trialObstet Gynecol20061081414816816054
- PachmanDRJonesJMLoprinziCLManagement of menopause-associated vasomotor symptoms: current treatment options, challenges and future directionsInt J Women’s Health20102123135
- LoprinziCLQinRBalcuevaEPPhase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1J Clin Oncol201028464164719901102
- StearnsVBeebeKLLyengarMDubeEParoxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trialJAMA2003289212827283412783913
- StearnsVSlackRGreepNParoxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trialJ Clin Oncol200523286919693016192581
- BartonDLLaVasseurBSloanJAA phase III trial evaluating three doses of citalopram for hot flashes: NCCTG trial N05C9J Clin Oncol201028203278328320498389
- FreemanEWGuthrieKACaanBEfficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trialJAMA2011305326727421245182
- LoprinziCLSloanJAPerezEAPhase III evaluation of fluoxetine for treatment of hot flashesJ Clin Oncol20022061578158311896107
- KimmickGGLovatoJMcQuellonRRobinsonEMussHBRandomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifenBreast J200612211412216509835
- GordonPRKerwinJPBoesenKGSenfJSertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general populationMenopause200613456857516837878
- JoffeHSoaresCNPetrilloLFTreatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetineJ Clin Psychiatry200768694395017592922
- LoprinziCLKuglerJWSloanJAVenlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trialLancet200035692472059206311145492
- LoprinziCLLevittRBartonDPhase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7J Clin Oncol20062491409141416505409
- DeecherDCAlfinitoPDLeventhalLAlleviation of thermoregulatory dysfunction with the new serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized rodent modelsEndocrinology200714831376138317122073
- SperoffLGassMConstantineGOlivierSEfficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trialObstet Gynecol20081111778718165395
- ArcherDFDupontCMConstantineGDPickarJHOlivierSDesvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safetyAm J Obstet Gynecol20092003238. e1238. e1019167693
- ArcherDFSeidmanLConstantineGDPickarJHOlivierSA double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopauseAm J Obstet Gynecol20092002172. e1172. e1019110224
- BouchardPPanayNde VilliersTJRandomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptomsClimacteric2012151122022066790
- GallagherJCStrzinekRAChengRFAusmanasMKAstlDSeljanPThe effect of dose titration and dose tapering on the tolerability of desvenlafaxine in women with vasomotor symptoms associated with menopauseJ Womens Health2012212188198